Low-dose combination remission induction therapy for acute myeloid leukaemia in elderly patients - a pilot study

Australian and New Zealand Journal of Medicine ◽

10.1111/j.1445-5994.1992.tb04888.x ◽

1992 ◽

Vol 22 (6) ◽

pp. 710-711 ◽

Author(s):

A. MANOHARAN

Keyword(s):

Pilot Study ◽

Elderly Patients ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Induction Therapy ◽

Low Dose ◽

Remission Induction ◽

Dose Combination ◽

Download Full-text

Low-dose combination remission induction therapy for acute myeloid leukaemia in elderly patients – a pilot study

Internal Medicine Journal ◽

10.1111/j.1445-5994.1992.tb00521.x ◽

1992 ◽

Vol 22 (6) ◽

pp. 710-711

Author(s):

A. MANOHARAN

Keyword(s):

Pilot Study ◽

Elderly Patients ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Induction Therapy ◽

Low Dose ◽

Remission Induction ◽

Dose Combination ◽

Download Full-text

Low-dose Gemtuzumab-Ozogamicin as post-consolidation therapy in elderly patients with acute myeloid leukaemia: a pilot study

British Journal of Haematology ◽

10.1111/j.1365-2141.2010.08168.x ◽

2010 ◽

Author(s):

Antonella Poloni ◽

Debora Capelli ◽

Silvia Trappolini ◽

Benedetta Costantini ◽

Mauro Montanari ◽

...

Keyword(s):

Pilot Study ◽

Elderly Patients ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Low Dose ◽

Gemtuzumab Ozogamicin ◽

Consolidation Therapy ◽

Download Full-text

Continuous drip infusion of low dose cytarabine and etoposide with granulocyte colony-stimulating factor for elderly patients with acute myeloid leukaemia ineligible for intensive chemotherapy

Hematological Oncology ◽

10.1002/hon.834 ◽

2008 ◽

Vol 26 (1) ◽

pp. 33-38 ◽

Author(s):

Nobuhiro Kanemura ◽

Hisashi Tsurumi ◽

Senji Kasahara ◽

Takeshi Hara ◽

Toshiki Yamada ◽

...

Keyword(s):

Elderly Patients ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Low Dose ◽

Intensive Chemotherapy ◽

Granulocyte Colony Stimulating Factor ◽

Colony Stimulating Factor ◽

Stimulating Factor ◽

Low Dose Cytarabine ◽

Download Full-text

Prognostic factors in children with acute myeloid leukaemia and excellent response to remission induction therapy

British Journal of Haematology ◽

10.1111/bjh.13107 ◽

2014 ◽

Vol 168 (1) ◽

pp. 94-101 ◽

Author(s):

Seth E. Karol ◽

Elaine Coustan-Smith ◽

Xueyuan Cao ◽

Sheila A. Shurtleff ◽

Susana C. Raimondi ◽

...

Keyword(s):

Prognostic Factors ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Induction Therapy ◽

Remission Induction ◽

Excellent Response ◽

Download Full-text

Therapeutic effects of different regimens for induction therapy in elderly patients more than 50 years old with newly diagnosed acute myeloid leukaemia

Translational Cancer Research ◽

10.21037/tcr.2018.12.21 ◽

2018 ◽

Vol 7 (6) ◽

pp. 1675-1681

Author(s):

Junmei Liu ◽

Liang Zhong ◽

Juanjuan Yao ◽

Pengqiang Zhong ◽

Zhen Yuan ◽

...

Keyword(s):

Elderly Patients ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Induction Therapy ◽

Therapeutic Effects ◽

Newly Diagnosed ◽

Download Full-text

Faculty Opinions recommendation of Low-dose melphalan induces favourable responses in elderly patients with high-risk myelodysplastic syndromes or secondary acute myeloid leukaemia.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1087261.540272 ◽

2007 ◽

Author(s):

Arnon Nagler

Keyword(s):

High Risk ◽

Elderly Patients ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Myelodysplastic Syndromes ◽

Low Dose ◽

Download Full-text

Low levels of mannose-binding lectin do not affect occurrence of severe infections or duration of fever in acute myeloid leukaemia during remission induction therapy

European Journal Of Haematology ◽

10.1034/j.1600-0609.2003.00012.x ◽

2003 ◽

Vol 70 (2) ◽

pp. 91-97 ◽

Author(s):

Olav J. Bergmann ◽

Michael Christiansen ◽

Inga Laursen ◽

Peter Bang ◽

Niels Ebbe Hansen ◽

...

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Induction Therapy ◽

Mannose Binding Lectin ◽

Remission Induction ◽

Mannose Binding ◽

Severe Infections ◽

Binding Lectin ◽

Download Full-text

Intestinal mucosal dysfunction and infection during remission-induction therapy for acute myeloid leukaemia

Leukemia ◽

10.1038/sj.leu.2404440 ◽

2006 ◽

Vol 20 (12) ◽

pp. 2087-2092 ◽

Author(s):

E J Bow ◽

J B Meddings

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Induction Therapy ◽

Remission Induction ◽

Download Full-text

Humoral immunity of the oral cavity during remission-induction therapy in patients with acute myeloid leukaemia

European Journal Of Haematology ◽

10.1111/j.1600-0609.1990.tb00398.x ◽

2009 ◽

Vol 44 (5) ◽

pp. 296-301 ◽

Author(s):

Olav J. Bergmann

Keyword(s):

Oral Cavity ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Humoral Immunity ◽

Induction Therapy ◽

Remission Induction ◽

Download Full-text

Successful remission induction therapy with gilteritinib in a patient with de novo FLT3 ‐mutated acute myeloid leukaemia and severe COVID‐19

British Journal of Haematology ◽

10.1111/bjh.16962 ◽

2020 ◽

Vol 190 (4) ◽

Author(s):

Andrew J. Wilson ◽

Ethan Troy‐Barnes ◽

Maryam Subhan ◽

Fiona Clark ◽

Rajeev Gupta ◽

...

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Induction Therapy ◽

De Novo ◽

Remission Induction ◽

Download Full-text